Malady Kyle 4
Research Summary
AI-generated summary
Verizon EVP Kyle Malady Receives Phantom Stock Award
What Happened Kyle Malady, EVP and Group CEO — VZ Business at Verizon Communications (VZ), was granted 129.363 units of phantom stock (transaction code A) on May 7, 2026. The units are reported at $13.44 each, totaling about $1,739. This was an award (compensation/derivative grant), not an open‑market purchase or sale.
Key Details
- Transaction date: May 7, 2026; Filing date: May 11, 2026 (appears 4 days after the transaction; Form 4s are normally due within two business days).
- Grant: 129.363 phantom stock units at $13.44 per unit — total value ≈ $1,739.
- Transaction type/code: A (award/acquisition of a derivative).
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes: F1 — each phantom share is an economic equivalent of a portion of a common share and is settled in cash under the deferred compensation plan; payable upon events established by the reporting person. F2 — includes phantom stock acquired through dividend reinvestment.
Context Phantom stock is a cash‑settled derivative that mimics economic exposure to common stock; it does not transfer actual common shares and is typically used for executive compensation or deferred pay. Because this was an award rather than a market purchase or sale, it should be viewed as compensation reporting rather than a direct bullish or bearish trading signal.